These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17456779)

  • 21. Expression of the cancer stem cell markers CD44v6 and ABCG2 in tongue cancer: effect of neoadjuvant chemotherapy on local recurrence.
    Yanamoto S; Yamada S; Takahashi H; Naruse T; Matsushita Y; Ikeda H; Shiraishi T; Seki S; Fujita S; Ikeda T; Asahina I; Umeda M
    Int J Oncol; 2014 Apr; 44(4):1153-62. PubMed ID: 24504189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of breast cancer resistance protein in liver cirrhosis, hepatocellular carcinoma and peritumoral tissues].
    Wang YM; Huang GS; Hui YP; Zhang J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):227-9. PubMed ID: 19335991
    [No Abstract]   [Full Text] [Related]  

  • 23. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
    Hiraga T; Ito S; Nakamura H
    Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of the ATP-binding cassette half-transporter, ABCG2 (Mxr/BCrp/ABCP1), in flavopiridol-resistant human breast cancer cells.
    Robey RW; Medina-Pérez WY; Nishiyama K; Lahusen T; Miyake K; Litman T; Senderowicz AM; Ross DD; Bates SE
    Clin Cancer Res; 2001 Jan; 7(1):145-52. PubMed ID: 11205902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer resistance protein (BCRP/ABCG2) is expressed by progenitor cells/reactive ductules and hepatocytes and its expression pattern is influenced by disease etiology and species type: possible functional consequences.
    Vander Borght S; Libbrecht L; Katoonizadeh A; van Pelt J; Cassiman D; Nevens F; Van Lommel A; Petersen BE; Fevery J; Jansen PL; Roskams TA
    J Histochem Cytochem; 2006 Sep; 54(9):1051-9. PubMed ID: 16709727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells.
    Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H
    Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.
    Kim M; Turnquist H; Jackson J; Sgagias M; Yan Y; Gong M; Dean M; Sharp JG; Cowan K
    Clin Cancer Res; 2002 Jan; 8(1):22-8. PubMed ID: 11801536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ABCG2 expression is an independent unfavorable prognostic factor in esophageal squamous cell carcinoma.
    Tsunoda S; Okumura T; Ito T; Kondo K; Ortiz C; Tanaka E; Watanabe G; Itami A; Sakai Y; Shimada Y
    Oncology; 2006; 71(3-4):251-8. PubMed ID: 17671398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice.
    Ogasawara S; Akiba J; Nakayama M; Nakashima O; Torimura T; Yano H
    J Gastroenterol Hepatol; 2015 Feb; 30(2):413-20. PubMed ID: 25087473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G; Chen X; Wang Q; Xu Z; Zhang W; Ye L
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr; 27(2):173-5. PubMed ID: 17497289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer resistance protein identifies clonogenic keratinocytes in human interfollicular epidermis.
    Ma D; Chua AW; Yang E; Teo P; Ting Y; Song C; Lane EB; Lee ST
    Stem Cell Res Ther; 2015 Mar; 6(1):43. PubMed ID: 25881149
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.
    Liu T; Xu F; Du X; Lai D; Liu T; Zhao Y; Huang Q; Jiang L; Huang W; Cheng W; Liu Z
    Mol Cell Biochem; 2010 Jul; 340(1-2):265-73. PubMed ID: 20224986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of ATP-binding cassette transporter ABCG2 in gastric carcinoma and its significance].
    Wang N; Chen L; Wei B; Zhao XY; Lu WJ; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Sep; 10(5):450-3. PubMed ID: 17851787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional expression of ABCG2 transporter in human neural stem/progenitor cells.
    Islam MO; Kanemura Y; Tajria J; Mori H; Kobayashi S; Hara M; Yamasaki M; Okano H; Miyake J
    Neurosci Res; 2005 May; 52(1):75-82. PubMed ID: 15811555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. C/EBPα-dependent preneoplastic tumor foci are the origin of hepatocellular carcinoma and aggressive pediatric liver cancer.
    Cast A; Valanejad L; Wright M; Nguyen P; Gupta A; Zhu L; Shin S; Timchenko N
    Hepatology; 2018 May; 67(5):1857-1871. PubMed ID: 29159818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
    Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
    World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer, side population cells and ABCG2 expression.
    Britton KM; Eyre R; Harvey IJ; Stemke-Hale K; Browell D; Lennard TWJ; Meeson AP
    Cancer Lett; 2012 Oct; 323(1):97-105. PubMed ID: 22521545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrodifferentiation of Human Tumor Hepatocytes to Stem Cells Leads to Metabolic Reprogramming and Chemoresistance.
    Fekir K; Dubois-Pot-Schneider H; Désert R; Daniel Y; Glaise D; Rauch C; Morel F; Fromenty B; Musso O; Cabillic F; Corlu A
    Cancer Res; 2019 Apr; 79(8):1869-1883. PubMed ID: 30837223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma.
    Lin S; Zhou S; Jiang S; Liu X; Wang Y; Zheng X; Zhou H; Li X; Cai X
    Oncol Rep; 2016 Aug; 36(2):853-62. PubMed ID: 27349376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.